- Home
- NCNA vs HSCS Comparison
NCNA vs HSCS Comparison
Compare NCNA & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCNA
- HSCS
- Stock Information
- Founded
- NCNA 1997
- HSCS 2007
- Country
- NCNA United Kingdom
- HSCS United States
- Employees
- NCNA N/A
- HSCS N/A
- Industry
- NCNA Biotechnology: Pharmaceutical Preparations
- HSCS Medical Specialities
- Sector
- NCNA Health Care
- HSCS Health Care
- Exchange
- NCNA Nasdaq
- HSCS Nasdaq
- Market Cap
- NCNA 3.4M
- HSCS 2.8M
- IPO Year
- NCNA 2017
- HSCS 2022
- Fundamental
- Price
- NCNA $0.97
- HSCS $2.80
- Analyst Decision
- NCNA Buy
- HSCS Strong Buy
- Analyst Count
- NCNA 2
- HSCS 2
- Target Price
- NCNA $25.00
- HSCS $13.00
- AVG Volume (30 Days)
- NCNA 118.8K
- HSCS 13.0K
- Earning Date
- NCNA 05-15-2025
- HSCS 03-13-2025
- Dividend Yield
- NCNA N/A
- HSCS N/A
- EPS Growth
- NCNA N/A
- HSCS N/A
- EPS
- NCNA N/A
- HSCS N/A
- Revenue
- NCNA N/A
- HSCS N/A
- Revenue This Year
- NCNA N/A
- HSCS N/A
- Revenue Next Year
- NCNA N/A
- HSCS N/A
- P/E Ratio
- NCNA N/A
- HSCS N/A
- Revenue Growth
- NCNA N/A
- HSCS 261.17
- 52 Week Low
- NCNA $0.69
- HSCS $2.36
- 52 Week High
- NCNA $10.79
- HSCS $13.50
- Technical
- Relative Strength Index (RSI)
- NCNA 48.38
- HSCS 40.13
- Support Level
- NCNA $0.81
- HSCS $2.75
- Resistance Level
- NCNA $1.34
- HSCS $2.95
- Average True Range (ATR)
- NCNA 0.14
- HSCS 0.15
- MACD
- NCNA 0.02
- HSCS 0.00
- Stochastic Oscillator
- NCNA 29.20
- HSCS 11.90
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.